4 September 2024 - NICE has published final evidence-based recommendations on the use of vibegron (Obgemsa) for the treatment of adults with symptoms of overactive bladder syndrome.

Vibegron is recommended as an option for the treatment of adults with symptoms of overactive bladder syndrome. It is only recommended if the use of muscarinic receptor antagonists are not suitable, do not work well enough or have unacceptable adverse effects.

Read NICE technology appraisal guidance